Jürgen Knoblich Explained

Jürgen Knoblich (born 1963 in Memmingen, Germany)[1] is a German molecular biologist. Since 2018, he is the interim Scientific Director of the Institute of Molecular Biotechnology[2] (IMBA) of the Austrian Academy of Sciences in Vienna.   

Education and career

Knoblich[3] studied Biochemistry at the University of Tübingen and Molecular Biology at University College London. In 1989 he transferred to the Max Planck Institute for Developmental Biology in Tübingen, where he completed his doctoral thesis in 1994 on the role of Cyclin proteins in controlling cell cycle progression during development. In 1994 he became a postdoctoral researcher at the University of California, San Francisco, where he worked with Dr. Yuh Nung Jan until 1997. Upon his return to Europe he joined the Institute of Molecular Pathology (IMP) in Vienna, Austria as a group leader. In 2004, he moved to the newly founded Institute of Molecular Biotechnology (IMBA) in Vienna, where he was appointed deputy director in 2005 and became scientific director in 2018.[4] Both the IMP and the IMBA are members of the Vienna Biocenter. Since 2021 he is chair in Synthetic Biology at Medical University of Vienna.[5]

Research focus

Knoblich’s research[6] is known for the development [7] of an organoid model of early human brain development,[8] [9] together with his postdoctoral fellow Madeline A. Lancaster. His team was the first to demonstrate that organoids derived from human pluripotent stem cells (iPS cells) can be used to model human disease, a breakthrough that was ranked within the top 10 scientific discoveries in 2013 by Science magazine.[10]

This model is now commonly referred to as “Cerebral organoids”. It recapitulates the early steps of human brain development during the first trimester and has been used by many other research groups.[11] [12] Organoid models enable researches to perform studies directly on human tissues that can be grown from any human individual.[13] They allow scientists to efficiently transfer research findings from fruit flies and animal models to human tissues and thus to investigate heritable genetic brain diseases on human tissue.

Since 2013 his team have developed cerebral organoids. In 2017, they showed that by fusing two separately patterned organoids it is possible to study interactions between distinct brain areas.[14]

Previously, his research had also centered around the mechanisms of brain development. His were neuronal stem cells, their asymmetrical cell division and processes of growth control. Building on his post-doctoral work, Knoblich and his colleagues characterized a complete mechanism for asymmetrical stem cell division in neural stem cells of the fruitfly Drosophila. Their results were published in a series of seminal papers, including a report in Cell in 2008.[15] Until then, it was unknown how stem cells can separate into a self-renewing daughter cell and a specialized differentiating cell at the same time. Asymmetric cell division is based on a reaction cascade in which a cascade of molecular switches are activated or inactivated. Proteins in this cascade are either turned “on” or “off” depending on their phosphorylation state, starting with a kinase that transfers the first phosphate residue, named aurora kinase A. Aurora kinase A is often over-expressed in tumor cells, alongside other molecules that also play a role in the process of asymmetric cell division. Since stem cell mitosis is a highly conserved process, results found in fruit flies can be transferred to humans and thereby help to gain insights into general tumor neogenesis[16]

Additionally, Knoblich and his group were the first to carry out a genome-wide in vivo RNAi screen to demonstrate for the first time, that it is possible to simultaneously analyze gene functions across the whole genome of an organism in a tissue specific manner.[17] This was achieved using a fruit fly gene bank generated at IMBA by Barry Dickson, in which every single one of the approximately 13,000 fruit fly genes can be inactivated in any cell independently. These findings have been published in Nature in 2009.[18] With this method, Knoblich could further elucidate brain tumor development in fruit flies. Recent findings suggest that tumors can be based on stem cells, that keep their unique stem cell characteristics and thus uncontrollably divide, without ever differentiating into specific somatic cell types. This lack of differentiation is caused by Brat, a gene that has been identified by Knoblich and his team.[19] It is currently unknown how many genes with a similar function exist in humans. Knoblich’s research group at IMBA is trying to identify more of these genes in order to develop less invasive therapies for cancer in the future.

Selected publications

Honors

Notes and References

  1. Web site: CV Knoblich. Jürgen. Knoblich. IMBA.
  2. Web site: Jürgen Knoblich - Team. IMBA - Institute of Molecular Biotechnology.
  3. Web site: Juergen A Knoblich PhD IMBA Institute Of Molecular Biotechnology, Vienna .. ResearchGate. 16 July 2019.
  4. Web site: IMBA. www.ccc.ac.at. 4 May 2020.
  5. Web site: Vienna. Medical University of. Jürgen Knoblich appointed Chair in Synthetic Biology at MedUni Vienna MedUni Vienna. 2 July 2021. Medical University of Vienna. en.
  6. Web site: knoblich j - PubMed - NCBI. pubmeddev. www.ncbi.nlm.nih.gov. 16 July 2019.
  7. Web site: Eppendorf Nature. www.nature.com. en. 4 May 2020.
  8. Web site: Dr. Jürgen Knoblich Talks Organoids. www.stemcell.com. 19 November 2019.
  9. Lancaster. Madeline A.. Knoblich. Juergen A.. October 2014. Generation of cerebral organoids from human pluripotent stem cells. Nature Protocols. 9. 10. 2329–2340. 10.1038/nprot.2014.158. 1750-2799. 4160653. 25188634.
  10. Web site: Science's Top 10 Breakthroughs of 2013. 19 December 2013. Science AAAS. 19 November 2019.
  11. Jg. Camp. F. Badsha. M. Florio. S. Kanton. T. Gerber. M. Wilsch-Bräuninger. E. Lewitus. A. Sykes. W. Hevers. 22 December 2015. Human Cerebral Organoids Recapitulate Gene Expression Programs of Fetal Neocortex Development. Proceedings of the National Academy of Sciences of the United States of America. en. 112. 51. 15672–7. 2015PNAS..11215672G. 10.1073/pnas.1520760112. 4697386. 26644564. free.
  12. Ma. Lancaster. M. Renner. Ca. Martin. D. Wenzel. Ls. Bicknell. Me. Hurles. T. Homfray. Jm. Penninger. Ap. Jackson. 19 September 2013. Cerebral Organoids Model Human Brain Development and Microcephaly. Nature. en. 501. 7467. 373–9. 2013Natur.501..373L. 10.1038/nature12517. 3817409. 23995685.
  13. Hynds. Robert E.. Giangreco. Adam. March 2013. The relevance of human stem cell-derived organoid models for epithelial translational medicine. Stem Cells. 31. 3. 417–422. 10.1002/stem.1290. 1066-5099. 4171682. 23203919.
  14. Bagley. Joshua A.. Reumann. Daniel. Bian. Shan. Lévi-Strauss. Julie. Knoblich. Juergen A.. July 2017. Fused cerebral organoids model interactions between brain regions. Nature Methods. 14. 7. 743–751. 10.1038/nmeth.4304. 1548-7105. 5540177. 28504681.
  15. Linking Cell Cycle to Asymmetric Division: Aurora-A Phosphorylates the Par Complex to Regulate Numb Localization. F. Wirtz-Peitz. T. Nishimura. 3 October 2008. Cell. en. 18854163. Ja. Knoblich. 135. 1. 161–73. 10.1016/j.cell.2008.07.049. 2989779.
  16. Linking Cell Cycle to Asymmetric Division: Aurora-A Phosphorylates the Par Complex to Regulate Numb Localization. F. Wirtz-Peitz. T. Nishimura. 3 October 2008. Cell. en. 18854163. Ja. Knoblich. 135. 1. 161–73. 10.1016/j.cell.2008.07.049. 2989779.
  17. Genome-wide Analysis of Notch Signalling in Drosophila by Transgenic RNAi. Jl. Mummery-Widmer. M. Yamazaki. 23 April 2009. en. 19363474. T. Stoeger. M. Novatchkova. S. Bhalerao. D. Chen. G. Dietzl. Bj. Dickson. Ja. Knoblich. Nature. 458. 7241. 987–92. 10.1038/nature07936. 2988197. 2009Natur.458..987M.
  18. Mummery-Widmer. Jennifer L.. Yamazaki. Masakazu. Stoeger. Thomas. Novatchkova. Maria. Bhalerao. Sheetal. Chen. Doris. Dietzl. Georg. Dickson. Barry J.. Knoblich. Juergen A.. 23 April 2009. Genome-wide analysis of Notch signalling in Drosophila by transgenic RNAi. Nature. 458. 7241. 987–992. 10.1038/nature07936. 1476-4687. 2988197. 19363474. 2009Natur.458..987M.
  19. The Tumor Suppressor Brat Controls Neuronal Stem Cell Lineages by Inhibiting Deadpan and Zelda. I. Reichardt. F. Bonnay. January 2018 . en. 29191977. V. Steinmann. I. Loedige. Tr. Burkard. G. Meister. Ja. Knoblich. EMBO Reports. 19. 1. 102–117. 10.15252/embr.201744188. 5757284.
  20. Web site: EMBO YIP.
  21. Web site: EMBO Young Investigator Meeting 2018 at the Vienna BioCenter. Pathology. Research Institute of Molecular. The Research Institute of Molecular Pathology. en. 4 May 2020.
  22. Web site: Wittgenstein-Preise 2009 an Jürgen Knoblich und Gerhard Widmer. OTS.at. de. 4 May 2020.
  23. Web site: Wiener Zeitung. 16 July 2019.
  24. Web site: ERC FUNDED PROJECTS. ERC: European Research Council. 19 November 2019.
  25. Web site: Academy of Europe: Knoblich Juergen Arthur. www.ae-info.org. 19 November 2019.
  26. Web site: Cerebral organoids: an innovative treatment for neurological disorders. 25 July 2018. ERC: European Research Council. en. 1 June 2020.
  27. Web site: ERC FUNDED PROJECTS. 2 July 2020. ERC: European Research Council. en.
  28. Web site: Rinunce e nomine. 9 October 2020. press.vatican.va.
  29. Web site: MedUni Wien.
  30. News: Preise der Stadt Wien 2021 für herausragende Leistungen in Kultur und Wissenschaft. 2 September 2021. OTS.at. de.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Jürgen Knoblich".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.